Subchronic microcystin-lr exposure increased hepatic apoptosis and induced compensatory mechanisms in mice

Journal of Biochemical and Molecular Toxicology

Volumn 26, Issue 4, 2012, Pages 131-138

  Lezcano, Noelia ^a   Sedán, Daniela ^b   Lucotti, Ignacio ^a   Giannuzzi, Leda ^b   Vittone, Leticia ^a   Andrinolo, Darío ^b   Mundiña Weilenmann, Cecilia ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b CENTRO DE INVESTIGACIÓN Y DESARROLLO EN CRIOTECNOLOGÍA DE ALIMENTOS CIDCA   (Argentina)

Author keywords

Apoptosis; Microcystin; Phosphatase Activity; Prolonged Exposure; Signaling Pathways

Indexed keywords

ALPHA TUBULIN; MICROCYSTIN LR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2; SERINE THREONINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ENZYME ACTIVATION; HEART; INJECTIONS, INTRAPERITONEAL; KIDNEY; LIVER; MALE; MICE; MICROCYSTINS; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUBULIN;

ANIMALIA; CYANOBACTERIA; MUS;

EID: 84859837336     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.20419     Document Type: Article

References (42)

1. WHO. Guidelines for drinking-water quality. Recommendations. Chemical fact sheets, 3rd edition. World Health Organization, Geneva, Switzerland; 2008. Vol 1, pp 407-408.
2. Ueno Y, Nagata S, Tsutsumi T, Hasegawa A, Watanabe MF, Park HD, Chen GC, Chen G, Yu SZ. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis. 1996;17:1317-1321.
3. Chen J, Xie P, Li L, Xu J. First identification of the hepatotoxic microcystins in the serum of a chronically exposed human population together with indication of hepatocellular damage. Toxicol Sci. 2009;108:81-89.
4. Li H, Xie P, Li G, Hao L, Xiong Q. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins. Toxicon. 2009;53:169-175.
5. Gehringer MM. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response. FEBS Lett. 2004;557:1-3.
6. 3H-dihydromicrocystin-LR, a cyclic peptide toxin. Biochim Biophys Acta. 1990;1025:60-66.
7. Fischer WJ, Altheimer S, Cattori V, Meier PJ, Dietrich DR, Hagenbuch B. Organic anion transporting polypeptides expressed in liver and brain mediate uptake of microcystin. Toxicol Appl Pharmacol. 2005;203:257-263.
8. Milutinović A, Zivin M, Zorc-Pleskovic R, Sedmak B, Suput D. Nephrotoxic effects of chronic administration of microcystins-LR and -YR. Toxicon 2003;42:281-288.
9. Andrinolo D, Sedan D, Telese L, Aura C, Masera S, Giannuzzi L, Marra C, Alaniz MT. Recovery after damage produced by subchronic intoxication with the cyanotoxin microcystin LR. Toxicon 2008;51:457-467.
10. Sedan D, Andrinolo D, Telese L, Giannuzzi L, de Alaniz MJ, Marra CA. Alteration and recovery of the antioxidant system induced by sub-chronic exposure to microcystin-LR in mice: its relation to liver lipid composition. Toxicon. 2010;55:333-342.
11. Milutinović A, Zorc-Pleskovic R, Petrovic D, Zorc M, Suput D. Microcystin-LR induces alterations in heart muscle. Folia Biol (Praha). 2006;52:116-118.
12. Qiu T, Xie P, Liu Y, Li G, Xiong Q, Hao L, Li H. The profound effects of microcystin on cardiac antioxidant enzymes, mitochondrial function and cardiac toxicity in rat. Toxicology. 2009;257:86-94.
13. MacKintosh C, Beattie KA, Klumpp S, Cohen P, Codd GA. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 1990;264:187-192.
14. Runnegar M, Kong S, Berndt N. Protein phosphatase inhibition and in vivo hepatotoxicity of microcystins. Am J Physiol. 1993;265:G224-G230.
15. Ding WX, Shen HM, Ong CN. Critical role of reactive oxygen species formation in microcystin-induced cytoskeleton disruption in primary cultured hepatocytes. J Toxicol Environ Health A. 2001;64:507-519.
16. Moreno I, Pichardo S, Jos A, Gómez-Amores L, Mate A, Vazquez CM, Cameán AM. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to MC-LR administered intraperitoneally. Toxicon. 2005;45:395-402.
17. Campos A, Vasconcelos V. Molecular mechanisms of microcystin toxicity in animal cells. Int J Mol Sci. 2010;11:268-287.
18. 2+/calmodulin-dependent protein kinase II is required for microcystin-induced apoptosis. J Biol Chem. 2002;277:2804-2811.
19. Krakstad C, Herfindal L, Gjertsen BT, Bøe R, Vintermyr OK, Fladmark KE, Døskeland SO. CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ 2006; 13:1191-1202.
20. Komatsu M, Furukawa T, Ikeda R, Takumi S, Nong Q, Aoyama K, Akiyama S, Keppler D, Takeuchi T. Involvement of mitogen-activated protein kinase signaling pathways in microcystin-LR-induced apoptosis after its selective uptake mediated by OATP1B1 and OATP1B3. Toxicol Sci. 2007;97:407-416.
21. Dias E, Matos P, Pereira P, Batoréu MC, Silva MJ, Jordan P. Microcystin-LR activates the ERK1/2 kinases and stimulates the proliferation of the monkey kidney-derived cell line Vero-E6. Toxicol In Vitro. 2010;24:1689-1695.
22. Ito E, Kondo F, Terao K, Harada K. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR. Toxicon 1997;35:1453-1457.
23. Solter PF, Wollenberg GK, Huang X, Chu FS, Runnegar MT. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects. Toxicol Sci. 1998;44:87-96.
24. Guzman RE, Solter PF. Characterization of sublethal microcystin-LR exposure in mice. Vet Pathol. 2002;39:17-26.
25. Zhang X, Xie P, Li D, Shi Z, Wang J, Yuan G, Zhao Y, Tang R. Anemia induced by repeated exposure to cyanobacterial extracts with explorations of underlying mechanisms. Environ Toxicol. 2011;26:472-479.
26. Barco M, Lawton LA, Rivera J, Caixach J. Optimization of intracellular microcystin extraction for their subsequent analysis by high performance liquid chromatography. J Chromatogr A. 2005;1074:23-30.
27. Chen YM, Lee TH, Lee SJ, Huang HB, Huang R, Chou HN. Comparison of protein phosphatase inhibition activities and mouse toxicities of microcystins. Toxicon. 2006;47:742-746.
28. MacKintosh C. Assay and purification of protein (serine/threonine phosphatases). In: D.G. Hardie, editor. Protein phosphorylation: A practical approach, New York: IRL Press; 1993; pp 197-230.
29. Swingle M, Ni L, Honkanen RE. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol Biol. 2007;365:23-38.
30. Mundiña-Weilenmann C, Vittone L, Cingolani HE, Orchard CH. Effects of acidosis on phosphorylation of phospholamban and troponin I in rat cardiac muscle. Am J Physiol. 1996;270:C107-C114.
31. Fu WY, Chen JP, Wang XM, Xu LH. Altered expression of p53, Bcl-2 and Bax induced by microcystin-LR in vivo and in vitro. Toxicon. 2005;46:171-177.
32. Weng D, Lu Y, Wei Y, Liu Y, Shen P. The role of ROS in microcystin-LR-induced hepatocyte apoptosis and liver injury in mice. Toxicology. 2007;232:15-23.
33. Ding WX, Shen HM, Ong CN. Microcystic cyanobacteria extract induces cytoskeletal disruption and intracellular glutathione alteration in hepatocytes. Environ Health Perspect. 2000;108:605-609.
34. Eriksson JE, Paatero GI, Meriluoto JA, Codd GA, Kass GE, Nicotera P, Orrenius S. Rapid microfilament reorganization induced in isolated rat hepatocytes by microcystin-LR, a cyclic peptide toxin. Exp Cell Res. 1989;185:86-100.
35. Ben-Ze'ev A, Farmer SR, Penman S. Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell. 1979;17:319-325.
36. Nebreda AR, Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci. 2000;25:257-260.
37. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene. 2007;26:3279-3290.
38. 2+/calmodulin dependent protein kinase II. Biochem J 2002;364:593-611.
39. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson ME. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133:462-474.
40. Toivola DM, Eriksson JE, Brautigan DL. Identification of protein phosphatase 2A as the primary target for microcystin-LR in rat liver homogenates. FEBS Lett. 1994;344:175-180.
41. Wang M, Chan LL, Si M, Hong H, Wang D. Proteomic analysis of hepatic tissue of zebrafish (Danio rerio) experimentally exposed to chronic microcystin-LR. Toxicol Sci 2010;113:60-69.
42. Wang M, Wang D, Lin L, Hong H. Protein profiles in zebrafish (Danio rerio) brains exposed to chronic microcystin-LR. Chemosphere 2010;81:716-724.